Immunyx Pharma
Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.
About
Immunyx is a drug development company focused on modulating neutrophil function in disease. They are developing a targeted neutrophil nanoparticle platform (TENNs) to address challenges in neutrophil therapy, aiming to provide effective and safe treatments for deregulated neutrophil damage in diseases like COPD, cancer, colitis, and arthritis. Their technology aims to modify neutrophil toxicity without causing neutropenia. Teams look it up for Life Sciences, Biopharmaceutical, Drug Development.
Frequently asked
What does Immunyx Pharma do?
Immunyx Pharma is a Life Sciences company that offers Services. Teams look it up for Biopharmaceutical, Drug Development, Biotech. It is based in New York, United States and was founded in 2017. Public records show about 6 people. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
Where is Immunyx Pharma headquartered?
Immunyx Pharma is headquartered in New York, United States.
When was Immunyx Pharma founded?
Immunyx Pharma was founded in 2017.
What industry does Immunyx Pharma operate in?
Immunyx Pharma operates in Life Sciences, Biopharmaceutical, Drug Development, Biotech, MedTech.
How many employees does Immunyx Pharma have?
Immunyx Pharma has approximately 6 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.